Sexual side effects and prostate cancer treatment decisions. Patient information needs and preferences

Cancer Journal

Volumn 15, Issue 1, 2009, Pages 41-44

  Knight, Sara J ^a   Latini, David M ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer treatment; Prostate; Sexual side effects

Indexed keywords

ARTICLE; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CANCER THERAPY; DECISION MAKING; ERECTILE DYSFUNCTION; HUMAN; IMPOTENCE; MALE SEXUAL DYSFUNCTION; MEDICAL INFORMATION; PRIORITY JOURNAL; PROSTATE CANCER; SEXUAL BEHAVIOR; SEXUAL COUNSELING; SEXUAL FUNCTION; SEXUALITY; TREATMENT OUTCOME;

EID: 61449219103     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e31819764cc     Document Type: Article

References (43)

1. Cox J, Amling CL. Current decision-making in prostate cancer therapy. Curr Opin Urol. 2008;18:275-278.
2. Wei JT, Uzzo RG. Shared decision-making strategies for early prostate cancer. Semin Urol Oncol. 2002;20:74-78.
3. Chen RC, Clark JA, Manola J, et al. Treatment 'mismatch' in early prostate cancer: do treatment choices take patient quality of life into account? Cancer. 2008;112:61-68.
4. Clark JA, Inui TS, Silliman RA, et al. Patients' perceptions of quality of life after treatment for early prostate cancer. J Clin Oncol. 2003;21:3777-3784.
5. Dale W, Bilir P, Han M, et al. The role of anxiety in prostate carcinoma: a structured review of the literature. Cancer. 2005;104:467-478.
6. Denberg TD, Melhado TV, Steiner JF. Patient treatment preferences in localized prostate carcinoma: the influence of emotion, misconception, and anecdote. Cancer. 2006;107:620-630.
7. Latini DM, Hart SL, Knight SJ, et al. The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance. J Urol. 2007;178(3 Pt 1):826-831; discussion 831-822.
8. Bokhour BG, Clark JA, Inui TS, et al. Sexuality after treatment for early prostate cancer: exploring the meanings of "erectile dysfunction." J Gen Intern Med. 2001;16:649-655.
9. Penson RT, Gallagher J, Gioiella ME, et al. Sexuality and cancer: conversation comfort zone. Oncologist. 2000;5:336-344.
10. Davison BJ, Goldenberg SL. Decisional regret and quality of life after participating in medical decision-making for early-stage prostate cancer. BJU Int. 2003;91:14-17.
11. Davison BJ, Parker PA, Goldenberg SL. Patients' preferences for communicating a prostate cancer diagnosis and participating in medical decision-making. BJU Int. 2004;93:47-51.
12. Kattan MW, Cowen ME, Miles BJ. A decision analysis for treatment of clinically localized prostate cancer. J Gen Intern Med. 1997;12:299-305.
13. Lubeck DP, Grossfeld GD, Carroll PR. A review of measurement of patient preferences for treatment outcomes after prostate cancer. Urology. 2002;60(3 Suppl 1):72-77; discussion 77-78.
14. Crawford ED, Bennett CL, Stone NN, et al. Comparison of perspectives on prostate cancer: analyses of survey data. Urology. 1997;50:366-372.
15. Sommers BD, Beard CJ, D'Amico AV, et al. Predictors of patient preferences and treatment choices for localized prostate cancer. Cancer. 2008;113:2058-2067.
16. Elstein AS, Chapman GB, Chmiel JS, et al. Agreement between prostate cancer patients and their clinicians about utilities and attribute importance. Health Expect. 2004;7:115-125.
17. Elstein AS, Chapman GB, Knight SJ. Patients' values and clinical substituted judgments: the case of localized prostate cancer. Health Psychol. 2005;24(4 Suppl):S85-S92.
18. Knight SJ, Nathan DP, Siston AK, et al. Pilot study of a utilities-based treatment decision intervention for prostate cancer patients. Clin Prostate Cancer. 2002;1:105-114.
19. Knight SJ, Siston AK, Chmiel JS, et al. Ethnic variation in localized prostate cancer: a pilot study of preferences, optimism, and quality of life among black and white veterans. Clin Prostate Cancer. 2004;3:31-37.
20. Carvalhal GF, Smith DS, Ramos C, et al. Correlates of dissatisfaction with treatment in patients with prostate cancer diagnosed through screening. J Urol. 1999;162:113-118.
21. Feldman-Stewart D, Brundage MD, Hayter C, et al. What questions do patients with curable prostate cancer want answered? Med Decis Making. 2000;20:7-19.
22. Boberg EW, Gustafson DH, Hawkins RP, et al. Assessing the unmet information, support and care delivery needs of men with prostate cancer. Patient Educ Couns. 2003;49:233-242.
23. Maliski SL, Connor S, Fink A, et al. Information desired and acquired by men with prostate cancer: data from ethnic focus groups. Health Educ Behav. 2006;33:393-409.
24. Albertsen PC, Nease RF Jr, Potosky AL. Assessment of patient preferences among men with prostate cancer. J Urol. 1998;159:158-163.
25. Saigal CS, Gornbein J, Nease R, et al. Predictors of utilities for health states in early stage prostate cancer. J Urol. 2001;166:942-946.
26. Cowen ME, Miles BJ, Cahill DF, et al. The danger of applying group-level utilities in decision analyses of the treatment of localized prostate cancer in individual patients. Med Decis Making. 1998;18:376-380.
27. Stewart ST, Lenert L, Bhatnagar V, et al. Utilities for prostate cancer health states in men aged 60 and older. Med Care. 2005;43:347-355.
28. Mazur DJ, Hickam DH. Patient preferences for management of localized prostate cancer. West J Med. 1996;165:26-30.
29. Smith DS, Krygiel J, Nease RF Jr, et al. Patient preferences for outcomes associated with surgical management of prostate cancer. J Urol. 2002;167:2117-2122.
30. Diefenbach MA, Dorsey J, Uzzo RG, et al. Decision-making strategies for patients with localized prostate cancer. Semin Urol Oncol. 2002;20:55-62.
31. Barry MJ. Health decision aids to facilitate shared decision making in office practice. Ann Intern Med. 2002;136:127-135.
32. Feldman-Stewart D, Brundage MD, Van Manen L. A decision aid for men with early stage prostate cancer: theoretical basis and a test by surrogate patients. Health Expect. 2001;4:221-234.
33. Myers RE, Kunkel EJ. Preparatory education for informed decision-making in prostate cancer early detection and treatment. Semin Urol Oncol. 2000;18:172-177.
34. Gomelk LG, Albertsen PC, Benson MC, et al. The use of video-based patient education for shared decision-making in the treatment of prostate cancer. Semin Urol Oncol. 2000;18:182-187.
35. Holmes-Rovner M, Nelson WL, Pignone M, et al. Are patient decision aids the best way to improve clinical decision making? Report of the IPDAS Symposium. Med Decis Making. 2007;27:599-608.
36. O'Connor AM, Bennett C, Stacey D, et al. Do patient decision aids meet effectiveness criteria of the international patient decision aid standards collaboration? A systematic review and meta-analysis. Med Decis Making. 2007;27:554-574.
37. Diefenbach MA, Butz BP. A multimedia interactive education system for prostate cancer patients: development and preliminary evaluation. J Med Internet Res. 2004;6:e3.
38. Kim SP, Knight SJ, Tomori C, et al. Health literacy and shared decision making for prostate cancer patients with low socioeconomic status. Cancer Invest. 2001;19:684-691.
39. McGregor S. Information on video format can help patients with localised prostate cancer to be partners in decision making. Patient Educ Couns. 2003;49:279-283.
40. Fagerlin A, Rovner D, Stableford S, et al. Patient education materials about the treatment of early-stage prostate cancer: a critical review. Ann Intern Med. 2004;140:721-728.
41. Fagerlin A, Zikmund-Fisher BJ, Ubel PA. Cure me even if it kills me: preferences for invasive cancer treatment. Med Decis Making. 2005;25:614-619.
42. Fagerlin A, Ubel PA, Smith DM, et al. Making numbers matter: present and future research in risk communication. Am J Health Behav. 2007;31 (Suppl 1):S47-S56.
43. Diefenbach MA, Mohamed NE. Regret of treatment decision and its association with disease-specific quality of life following prostate cancer treatment. Cancer Invest. 2007;25:449-457.